Related Experiment Video
Updated: May 23, 2026

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of Gold(III)
Published on: August 31, 2018
Effect of carbon black nanoparticles on the albumin secondary structure
Yuta Takahashi1, Samal Kaumbekova2, Naoya Sakaguchi1
1Department of Materials Science and Technology, Graduate School of Advanced Engineering, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan. masa-ume@rs.tus.ac.jp.
Abstract:
Nano-particulate air pollutants-particularly fine particle matter (PM2.5)-may cause several health issues, such as the accumulation of misfolded proteins in developing brains. However, the physicochemical molecular mechanism underlying nanoparticle (NP) toxicity remains poorly understood. This study investigates the effects of carbon black (CB) NPs (CB-NPs), with different surface properties and particle sizes, on the secondary structure of bovine serum albumin (BSA) using Fourier transform infrared and circular dichroism (CD) spectroscopic techniques, complemented by molecular dynamics (MD) simulations. The BSA sample incubated with CB-NPs exhibited no significant change when analyzed with excess BSA unbound to the NPs; however, CD spectroscopy revealed that Printex 90-a CB-NP with a smaller primary particle size and a more defective graphene structure-induced a notable change in the secondary structure of the adsorbed BSA. This change was characterized by a decrease in α-helix content and an increase in β-sheets. MD simulations further supported these findings, signifying that BSA monomers were adsorbed onto the CB-NP surface, leading to restricted protein mobility. This study provides crucial molecular-level insight into the role of carbonaceous NPs in triggering protein unfolding, a crucial step in NP toxicity.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Distribution: Plasma Protein Binding
Protein Folding
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...

